Low doses of ionizing radiation activate endothelial cells and induce angiogenesis in peritumoral tissues
2020; Elsevier BV; Volume: 151; Linguagem: Inglês
10.1016/j.radonc.2020.06.038
ISSN1879-0887
AutoresFilipa Gil Marques, Esmeralda Poli, João Malaquias, Tânia Carvalho, Ana Portêlo, Afonso Ramires, Fernando Aldeia, Ruy M. Ribeiro, Emília Vitorino, Isabel Diegues, Luís Lopes-da-Costa, Joào Coutinho, Filomena Pina, Marc Mareel, Susana Constantino Rosa Santos,
Tópico(s)Advanced Radiotherapy Techniques
ResumoDuring radiotherapy the peritumoral tissues are daily exposed to subtherapeutic doses of ionizing radiation. Herein, the biological and molecular effects of doses lower than 0.8 Gy per fraction (LDIR), previously described as angiogenesis inducers, were assessed in human peritumoral tissues.Paired biopsies of preperitoneal adipose tissue were surgically collected from 16 patients diagnosed with locally advanced rectal cancer who underwent neo-adjuvant radiotherapy. One of the biopsies is located in the vicinity of the region where the tumor received the prescribed dose of radiation, and thus exposed to LDIR; the other specimen, outside all beam apertures, was used as an internal calibrator (IC). Microvessel density (MDV) was quantified by immunohistochemistry and the expression of angiogenic, pro-inflammatory, adhesion and oxidative stress genes was assessed by quantitative RT-PCR using exclusively endothelial cells (ECs) isolated by laser capture microdissection microscopy.LDIR activated peritumoral ECs by significantly up-regulating the expression of several pro-angiogenic genes such as VEGFR1, VEGFR2, ANGPT2, TGFB2, VWF, FGF2, HGF and PDGFC and down-regulating the pro-inflammatory IL8 marker. Accordingly, the MVD was significantly increased in peritumoral tissues exposed to LDIR, compared to the IC. The patients that yielded a larger pro-angiogenic response, also showed the highest MVD.LDIR activate ECs in peritumoral tissues that are associated with increased MVD. Although the technological advances in radiotherapy have contributed to reduce the damage to healthy tissues over the past years, the anatomical regions receiving LDIR should be taken into account in the treatment plan report for patient follow-up and in future studies to correlate these doses with tumor dissemination.
Referência(s)